Total Payments
$14,587
2024 Payments
$2,225
Companies
42
Transactions
760
Medicare Patients
18,371
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$14,374 (98.5%)
Education$201.36 (1.4%)
Other$11.68 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,374 | 755 | 98.5% |
| Education | $201.36 | 4 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11.68 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,788 | 125 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,543 | 53 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,510 | 75 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,288 | 75 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,154 | 69 | $0 (2024) |
| Amgen Inc. | $775.35 | 55 | $0 (2024) |
| Boston Scientific Corporation | $726.43 | 10 | $0 (2024) |
| PFIZER INC. | $518.14 | 33 | $0 (2024) |
| Esperion Therapeutics, Inc. | $499.66 | 19 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $493.51 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,225 | 92 | Boehringer Ingelheim Pharmaceuticals, Inc. ($483.55) |
| 2023 | $1,834 | 77 | Boston Scientific Corporation ($448.57) |
| 2022 | $1,545 | 87 | Novartis Pharmaceuticals Corporation ($254.48) |
| 2021 | $1,773 | 99 | Novartis Pharmaceuticals Corporation ($274.21) |
| 2020 | $671.50 | 35 | AstraZeneca Pharmaceuticals LP ($212.12) |
| 2019 | $2,107 | 119 | Janssen Pharmaceuticals, Inc ($385.66) |
| 2018 | $2,091 | 119 | AstraZeneca Pharmaceuticals LP ($329.58) |
| 2017 | $2,340 | 132 | Novartis Pharmaceuticals Corporation ($371.13) |
All Payment Transactions
760 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Obesity | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/02/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.66 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Acist Medical Systems, Inc. | RXi Systems (Device) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Diagnostic Imaging | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $102.60 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/29/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardio-renal | ||||||
| 10/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiology | ||||||
| 09/23/2024 | Acist Medical Systems, Inc. | CVI Systems (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diagnostic Imaging | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.81 | General |
| Category: Cardiovascular | ||||||
| 09/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 4,251 | 7,494 | $1.7M | $383,736 |
| 2022 | 33 | 4,601 | 8,053 | $1.9M | $422,397 |
| 2021 | 30 | 4,743 | 8,487 | $2.0M | $453,247 |
| 2020 | 33 | 4,776 | 8,774 | $2.0M | $437,861 |
Total Patients
18,371
Total Services
32,808
Medicare Billing
$1.7M
Procedure Codes
127
All Medicare Procedures & Services
127 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 589 | 1,673 | $426,615 | $144,156 | 33.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 228 | 452 | $481,792 | $73,569 | 15.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 326 | 658 | $291,794 | $45,554 | 15.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 228 | 455 | $79,625 | $39,846 | 50.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 187 | 746 | $98,436 | $32,030 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $24,304 | $6,789 | 27.9% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 226 | 227 | $39,498 | $4,592 | 11.6% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 226 | 227 | $25,424 | $3,536 | 13.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 260 | 420 | $8,400 | $3,528 | 42.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 75 | 76 | $20,748 | $3,525 | 17.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 237 | 379 | $22,361 | $3,142 | 14.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 226 | 227 | $40,633 | $2,285 | 5.6% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 136 | 161 | $29,624 | $2,147 | 7.2% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 127 | 151 | $28,690 | $2,002 | 7.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $7,632 | $1,793 | 23.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 117 | 133 | $12,635 | $1,745 | 13.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 171 | 209 | $8,360 | $1,590 | 19.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 15 | $4,860 | $1,482 | 30.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 80 | 90 | $8,100 | $1,481 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 27 | $4,671 | $1,475 | 31.6% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 49 | 170 | $4,937 | $1,432 | 29.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 193 | 241 | $9,640 | $1,323 | 13.7% |
| 80076 | Liver function blood test panel | Office | 2023 | 122 | 142 | $8,094 | $1,137 | 14.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 19 | 38 | $4,826 | $1,081 | 22.4% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 191 | 239 | $10,277 | $1,037 | 10.1% |
About Dr. Lukas Jantac, M.D
Dr. Lukas Jantac, M.D is a Cardiovascular Disease healthcare provider based in Sanford, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750507463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lukas Jantac, M.D has received a total of $14,587 in payments from pharmaceutical and medical device companies, with $2,225 received in 2024. These payments were reported across 760 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($14,374).
As a Medicare-enrolled provider, Jantac has provided services to 18,371 Medicare beneficiaries, totaling 32,808 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 127 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Sanford, NC
- Active Since 04/18/2007
- Last Updated 01/23/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1750507463
Products in Payments
- ENTRESTO (Drug) $1,592
- JARDIANCE (Drug) $1,179
- XARELTO (Drug) $1,154
- BRILINTA (Drug) $975.36
- MULTAQ (Drug) $931.71
- ELIQUIS (Drug) $792.86
- LifeVest (Device) $493.51
- VERQUVO (Drug) $473.91
- Repatha (Biological) $464.48
- Vascepa (Drug) $436.64
- WATCHMAN FLX (Device) $421.14
- PRADAXA (Drug) $363.65
- PRALUENT (Drug) $355.96
- Corlanor (Drug) $310.87
- FARXIGA (Drug) $297.32
- NEXLETOL (Drug) $264.54
- NEXLIZET (Drug) $235.12
- WAINUA (Drug) $216.38
- LEQVIO (Drug) $195.84
- Kerendia (Drug) $184.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Sanford
Joseph Rossi, Md, MD
Cardiovascular Disease — Payments: $44,365
Cardiovascular Disease $44,365
Mahmoud Atieh, Md, MD
Cardiovascular Disease — Payments: $19,705
Cardiovascular Disease $19,705
Michael Gillespie, Md, MD
Cardiovascular Disease — Payments: $15,392
Cardiovascular Disease $15,392
Dr. Ashwani Sastry, Md, MD
Cardiovascular Disease — Payments: $12,240
Cardiovascular Disease $12,240
Dr. Prabhat Kumar, M.d, M.D
Cardiovascular Disease — Payments: $4,053
Cardiovascular Disease $4,053